ReviewCurrent oncology reports2010

Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?

Carla Casulo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.